XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (65,637) $ (49,620)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,428 2,705
Stock-based compensation 18,557 7,891
Change in right-of-use asset 1,292 1,388
Interest expense on notes and convertible debt 36 840
Amortization of debt issuance costs and debt discount 250 335
Change in fair value of warrant liabilities 406 6,097
Change in fair value of derivative liability 0 5,308
Gain on extinguishment of tranche right liability 0 (1,610)
Inventory write down 866 1,156
Changes in operating assets and liabilities:    
Accounts receivable (4,378) (2,023)
Inventory (2,551) (4,064)
Prepaid expenses and other assets 42 21
Accounts payable (2,707) (625)
Accrued and other liabilities 7,060 (2,001)
Operating lease liability (1,770) (429)
Net cash used in operating activities (45,106) (34,631)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchases of property and equipment (1,774) (2,394)
Net cash used in investing activities (1,774) (2,394)
Net Cash Provided by (Used in) Financing Activities [Abstract]    
Proceeds from the merger and private offering 291,454 0
Payment of offering costs (27,124) 0
Repayment of debt (7,000) (3,000)
Proceeds from issuance of promissory notes to related parties 5,000 0
Repayment of promissory notes to related parties (5,000) 0
Repurchase of common stock (43) 0
Proceeds from exercise of stock options 539 9
Issuance of common stock upon exercise of restricted stock awards 0 8
Proceeds from issuance of Series B redeemable convertible preferred stock, net of issuance cost of $265 0 41,526
Net cash provided by financing activities 257,826 38,543
Net increase in cash, cash equivalents and restricted cash 210,946 1,518
Cash, cash equivalents and restricted cash at beginning of period 12,642 18,405
Cash, cash equivalents and restricted cash at end of period 223,588 19,923
SUPPLEMENTAL DISCLOSURES OF OPERATING ACTIVITIES:    
Cash paid for interest 635 1,020
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION:    
Property and equipment purchases included in accounts payable and accrued liabilities 334 12
Private placement warrants acquired as part of the merger 19,377 0
Issuance of redeemable convertible preferred stock upon exercise of warrants 58,097 0
Conversion of redeemable convertible preferred stock to common stock 97,322 40,016
Right-of-use assets obtained in exchange for operating lease liability 0 6,234
Issuance of common stock pursuant to the conversion of convertible notes and accrued interest $ 0 $ 78,311